Vyome Holdings, Inc.
Vyome Holdings, Inc. (HIND) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HIND · as of Jun 8, 2026
Key Statistics
Explore Vyome Holdings, Inc. Data
hind stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 33.3%
The HIND analyst consensus is Hold, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $15.00, representing +584.93% upside from the current price of $2.19.
Competitors & Peers
hind competitorsHIND
ARMP
CCCC
CDXS
CGEN
IMDXStock Performance
Full HistoryAbout Vyome Holdings, Inc.
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflamm…
what is vyome holdings, inc. · hind stock overview · vyome holdings, inc. company profile · who is vyome holdings, inc. ceo · hind NASDAQ · vyome holdings, inc. headquarters · vyome holdings, inc. business segments
About Stock Overview & Key Data
Vyome Holdings, Inc. (HIND) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 6, 2016. As of the latest trading session, HIND stock price is $2.19, with a market capitalization of $12.3M. The stock has returned -78.94% over the past 12 months and -36.34% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Vyome Holdings, Inc. stock is Hold, with an average 12-month price target of $15.00. In fiscal year 2025, Vyome Holdings, Inc. reported revenue of $319714.00 and net income of -$10.3M. For detailed data — including Vyome Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Vyome Holdings, Inc. (HIND) stock price is $2.19. The stock is traded on NASDAQ under the ticker symbol HIND. The 52-week range is $1.75 – $20.76.